| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC2232 |
| Trial ID | NCT04154709 |
| Disease | Acute Lymphoblastic Leukemia |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CTA101 |
| Phase | Phase1 |
| Recruitment status | Unknown |
| Title | CTA101 UCAR-T Cell Injection for Treatment of Relapsed or Refractory CD19+ B-cell Acute Lymphoblastic Leukemia |
| Year | 2019 |
| Country | China |
| Company sponsor | Xuzhou Medical University |
| Other ID(s) | XYFY2019-KL135-02 |
| Cohort 1 | |||||||
|
|||||||